Immunomodulatory Strategies in Managing Immunosuppressive States in Infants

Immunosuppressive states in infants, whether congenital or acquired, present significant clinical challenges due to increased susceptibility to infections, immune dysregulation, and higher morbidity rates. These conditions stem from congenital immunodeficiencies, prematurity, maternal factors, and medical interventions, necessitating targeted immunomodulatory strategies. Effective approaches include pharmacologic agents such as immunoglobulin replacement therapy, cytokine therapy, and corticosteroids, as well as advanced cellular therapies like hematopoietic stem cell transplantation (HSCT) and gene therapy. Additionally, vaccination strategies and microbiota-based interventions play crucial roles in immune enhancement. This review highlights current and emerging immunomodulatory interventions, emphasizing their mechanisms, efficacy, and safety. A deeper understanding of these therapies can improve clinical outcomes, reduce complications, and enhance long-term immune function in affected populations.